JPWO2022016043A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022016043A5 JPWO2022016043A5 JP2023502828A JP2023502828A JPWO2022016043A5 JP WO2022016043 A5 JPWO2022016043 A5 JP WO2022016043A5 JP 2023502828 A JP2023502828 A JP 2023502828A JP 2023502828 A JP2023502828 A JP 2023502828A JP WO2022016043 A5 JPWO2022016043 A5 JP WO2022016043A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleotides
- dsrna
- nucleotide
- optionally
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063052811P | 2020-07-16 | 2020-07-16 | |
| US63/052,811 | 2020-07-16 | ||
| PCT/US2021/041946 WO2022016043A1 (en) | 2020-07-16 | 2021-07-16 | Conjugated oligonucleotides for tissue specific delivery |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023534951A JP2023534951A (ja) | 2023-08-15 |
| JPWO2022016043A5 true JPWO2022016043A5 (https=) | 2024-07-25 |
| JP2023534951A5 JP2023534951A5 (https=) | 2024-07-25 |
Family
ID=79554340
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023502828A Pending JP2023534951A (ja) | 2020-07-16 | 2021-07-16 | 組織特異的送達のためのコンジュゲートされたオリゴヌクレオチド |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20220042015A1 (https=) |
| EP (1) | EP4181932A4 (https=) |
| JP (1) | JP2023534951A (https=) |
| CN (1) | CN116600817A (https=) |
| AU (1) | AU2021308657A1 (https=) |
| CA (1) | CA3174068A1 (https=) |
| WO (1) | WO2022016043A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3033368A1 (en) * | 2016-08-12 | 2018-02-15 | University Of Massachusetts | Conjugated oligonucleotides |
| JP7627042B2 (ja) | 2018-08-23 | 2025-02-05 | ユニバーシティー オブ マサチューセッツ | Ｏ－メチルリッチ完全安定化オリゴヌクレオチド |
| US12365894B2 (en) | 2019-09-16 | 2025-07-22 | University Of Massachusetts | Branched lipid conjugates of siRNA for specific tissue delivery |
| WO2021242883A1 (en) | 2020-05-26 | 2021-12-02 | University Of Massachusetts | Synthetic oligonucleotides having regions of block and cluster modifications |
| US12366070B2 (en) | 2021-04-23 | 2025-07-22 | Stephen Cochran | Cover for circular-profile downspouts having protection from animal/insect intrusion and damage/debris accumulation |
| IL317825A (en) | 2022-07-25 | 2025-02-01 | Amgen Inc | RNA interference constructs and methods for inhibiting fam13a expression |
| US20260049309A1 (en) * | 2022-08-15 | 2026-02-19 | Novo Nordisk A/S | Regulation of activity of rnai molecules |
| WO2024069235A2 (en) | 2022-09-30 | 2024-04-04 | Sixfold Bioscience Ltd. | Compositions containing oligonucleotides with theranostic applications |
| WO2025217569A1 (en) * | 2024-04-11 | 2025-10-16 | University Of Massachusetts | Conjugated chemically-modified dsrna during ex vivo perfusion of organs |
| WO2025259747A2 (en) * | 2024-06-12 | 2025-12-18 | Alnylam Pharmaceuticals, Inc. | Dystrophy myotonic protein kinase (dmpk) irna compositions and methods of use thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9745574B2 (en) * | 2009-02-04 | 2017-08-29 | Rxi Pharmaceuticals Corporation | RNA duplexes with single stranded phosphorothioate nucleotide regions for additional functionality |
| CA3033368A1 (en) * | 2016-08-12 | 2018-02-15 | University Of Massachusetts | Conjugated oligonucleotides |
| EP3517610A4 (en) * | 2016-09-23 | 2020-05-27 | National University Corporation Tokyo Medical and Dental University | THROUGH HETERODUPLEX NUCLEIC ACID THROUGH BLOOD BRAIN CABINET |
| WO2019217459A1 (en) * | 2018-05-07 | 2019-11-14 | Alnylam Pharmaceuticals, Inc. | Extrahepatic delivery |
| JP2023550485A (ja) * | 2020-11-23 | 2023-12-01 | ユニバーシティー オブ マサチューセッツ | Ｄｇａｔ２調節のためのオリゴヌクレオチド |
-
2021
- 2021-07-16 CN CN202180061336.7A patent/CN116600817A/zh active Pending
- 2021-07-16 EP EP21843183.1A patent/EP4181932A4/en active Pending
- 2021-07-16 AU AU2021308657A patent/AU2021308657A1/en active Pending
- 2021-07-16 JP JP2023502828A patent/JP2023534951A/ja active Pending
- 2021-07-16 US US17/377,632 patent/US20220042015A1/en active Pending
- 2021-07-16 CA CA3174068A patent/CA3174068A1/en active Pending
- 2021-07-16 WO PCT/US2021/041946 patent/WO2022016043A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020536125A5 (https=) | ||
| JPWO2022109398A5 (https=) | ||
| JP2011517676A5 (https=) | ||
| JP2017217007A (ja) | ロックド核酸モチーフを含むオリゴヌクレオチドベースの阻害剤 | |
| JP2011517676A (ja) | インビボでｒｎａ干渉を媒介するための組成物および方法 | |
| JP2018516091A5 (https=) | ||
| JPWO2022016043A5 (https=) | ||
| ES2614115T3 (es) | Sistema de micelas inversas que comprenden ácidos nucleicos y su uso | |
| JP2016518841A (ja) | 細胞取り込みの向上のための化合物および方法 | |
| JPWO2021216556A5 (https=) | ||
| JPWO2020132227A5 (https=) | ||
| JPWO2020198509A5 (https=) | ||
| JPWO2020205605A5 (https=) | ||
| JPWO2021195307A5 (https=) | ||
| JP2022530678A (ja) | 短縮センス鎖を有する二本鎖核酸阻害剤分子 | |
| CN113227371A (zh) | 微型发夹RNAi触发物(mxRNA)和其使用方法 | |
| JPWO2022271786A5 (https=) | ||
| JPWO2021119226A5 (https=) | ||
| JP2023530072A (ja) | Ｐｍｐ２２を調節するための化合物及び方法 | |
| JPWO2022187435A5 (https=) | ||
| JP2026506091A (ja) | ハンチンチン発現を調節するための対立遺伝子選択的化合物及び方法 | |
| JPWO2021188661A5 (https=) | ||
| JP2026506010A (ja) | Ａｐｐ発現を低減するための化合物及び方法 | |
| JP2024501673A (ja) | 修飾核酸コンジュゲート | |
| JPWO2020139764A5 (https=) |